Nitazoxanide for Cryptosporidium in Children
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial tests a drug called nitazoxanide to see if it helps children clear a Cryptosporidium infection. It is looking for children who tested positive for the parasite and whose families can stay in the area for 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You tested positive for Cryptosporidium in a stool sample
- Your family will stay in the local area for the next 6 months
- You are not allergic to nitazoxanide (the study drug)
- You are not taking warfarin (a blood thinner)
- You have no history of kidney or liver problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, EDI048, to see how well it works and how safe it is for treating cryptosporidium infection. It is for healthy volunteers who will be intentionally exposed to the infection under controlled conditions.
This study follows children aged 6 months to 5 years with diarrhea caused by Cryptosporidium. It aims to understand how the infection develops over time and how it affects children.
This trial studies nitazoxanide to treat Helicobacter pylori, a common stomach infection, in children. If you test positive for this infection and haven’t been treated for it before, you may be able to join.
This trial tests if a 600 mg dose of nitazoxanide (an antiparasitic drug) can help outpatients with early COVID-19 or flu recover more quickly. If you've just tested positive for COVID-19 or influenza and your symptoms started less than 48 hours ago, this study might be for you.
This trial tests if a medication called nitazoxanide can help people with mild to moderate ulcerative colitis (UC). It may be a treatment option for those not already on strong UC medications.
This trial tests whether the herb echinacea (Immulant) can help treat cryptosporidiosis, a diarrheal infection, in children aged 5 to 12 whose immune systems are weakened. It aims to find a safe and effective treatment for these children.
Hear when a new Cryptosporidiosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.